Filing excerpt
Planned acquisition of Resonant Sciences, an EBITDA-positive defense technology company with $100 million-plus in trailing twelve-month revenue, to significantly expand Joby’s defense business, adding a fast-growing company with established programs, classified capabilities and scaled manufacturing operations